| Combination regimen | Drug | Dose (mg/m2) | Route | Day | Interval (day) |
|---|---|---|---|---|---|
| CAF | Cyclophophamide | 100 | PO | 1–14 | 28 |
| Doxorubicin | 30 | IV | 1, 8 | ||
| 5-Fluorouracil | 500 | IV | 1, 8 | ||
| FAC | 5-Fluorouracil | 500 | IV | 1, 8 or 1, 4 | 21 |
| Doxorubicin | 50 | IV | 1 | ||
| Cyclophophamide | 500 | IV | 1 | ||
| FEC | 5-Fluorouracil | 500 | IV | 1, 8 | 28 |
| Epirubicin | 60 | IV | 1, 8 | ||
| Cyclophophamide | 500 | IV | 1, 8 | ||
| AC | Doxorubicin | 60 | IV | 1 | 21 |
| Cyclophophamide | 600 | IV | 1 | ||
| EC | Epirubicin | 75 | IV | 1 | 21 |
| Cyclophophamide | 600 | IV | 1 | ||
| CMF | Cyclophophamide | 100 | PO | 1–14 | 28 |
| Methotrexate | 40 | IV | 1, 8 | ||
| 5-Fluorouracil | 600 | IV | 1, 8 | ||
| Docetaxel/capecitabine | Docetaxel | 75 | IV | 1 | 21 |
| Capecitabine | 950 | PO, 2/day | 1–14 | ||
| GT | Paclitaxel | 175 | IV | 1 | 21 |
| Gemcitabine | 1250 | IV | 1, 8 (after paclitaxel on 1st day) |